229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-27.73%
Both yoy net incomes decline, with VUZI at -12.07%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.12%
Less D&A growth vs. VUZI's 5.50%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-27.12%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
0.52%
Less SBC growth vs. VUZI's 423.24%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-2071.59%
Both reduce yoy usage, with VUZI at -240.16%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-138.88%
AR is negative yoy while VUZI is 4447.46%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-315.24%
Both reduce yoy inventory, with VUZI at -197.76%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
96.99%
A yoy AP increase while VUZI is negative at -459.63%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-95.71%
Both reduce yoy usage, with VUZI at -32.17%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
No Data
No Data available this quarter, please select a different quarter.
-37.40%
Both yoy CFO lines are negative, with VUZI at -340.97%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
12.31%
Some CapEx rise while VUZI is negative at -924.67%. John Neff would see competitor possibly building capacity while we hold back expansions.
-860.00%
Negative yoy acquisition while VUZI stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
5.58%
Purchases growth of 5.58% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
16.57%
Liquidation growth of 16.57% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-131.71%
Both yoy lines negative, with VUZI at -35.79%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
54.68%
We have mild expansions while VUZI is negative at -924.67%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-69.85%
Negative yoy issuance while VUZI is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.